Table7: Olaratumab simulation results.

True HR

Treat events

Control events

Bias

ASE

ESD

Median HR

Proportion of HR

< 0.5

< 0.4

< 0.3

1

57

57

-0.0012

0.1876

0.1876

1.00

0.0000

0.0000

0.0000

0.9

56

57

0.0029

0.1892

0.1919

0.90

0.0018

0.0004

0.0000

0.8

53

57

-0.0003

0.1915

0.1910

0.80

0.0070

0.0000

0.0000

0.7

51

57

-0.0023

0.1946

0.1953

0.70

0.0424

0.0048

0.0000